Zentalis Pharmaceuticals announced a restructuring to extend its cash runway into late 2027, following a planned 40% workforce reduction, in preparation for the potentially registration-enabling ...

ACM Research updates 2024 revenue outlook to $755-$770 million and projects $850-$950 million for 2025. ACM Research, Inc. has revised its revenue outlook for 2024 to a range of $755 million to $ ...

Overall, the company is transitioning from a clinical to a commercial stage, focusing on bringing innovative therapeutics to market ... Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience ...

Microsoft (MSFT) was the only of the seven stocks to not fall more than the Nasdaq's ... life's work in the private sector has given him a understanding of the economy and markets.

Microsoft (MSFT) was the only of the seven stocks to not fall more than the Nasdaq's 0.89% loss on the ... The nominee highlighted his life's work in the private sector has given him a understanding ...

KittyHawk focuses on investments across artificial intelligence, longevity, advanced materials, MedTech, FinTech, cybersecurity, robotics, aerospace, SaaS, climate, and more. Through its partnership ...

Nasdaq Private Market, LLC SAN FRANCISCO and NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Nasdaq Private Market (NPM), a premier provider of secondary liquidity solutions for private companies ...

The Offering raised net cash proceeds of approximately $2.9 million (after deducting the transfer agent and legal fees and expenses of the Offering). The Company intends to use the net cash proceeds ...